Literature DB >> 23702805

Colitis-induced bone loss is gender dependent and associated with increased inflammation.

Regina Irwin1, Taehyung Lee, Vincent B Young, Narayanan Parameswaran, Laura R McCabe.   

Abstract

BACKGROUND: Patients with inflammatory bowel disease (IBD) are at increase risk for bone loss and fractures. Therefore, in the present study, we examined the effect of experimental IBD on bone health.
METHODS: We used a murine model of colitis, Helicobacter hepaticus-infected interleukin-10-deficient animals. Molecular and histological properties of bone and intestine were examined to identify the immunopathological consequences of colitis in male and female mice.
RESULTS: At 6 weeks postinfection, we observed significant trabecular bone loss in male mice but surprisingly not in female mice. This was true for both distal femur and vertebral locations. In addition, H. hepaticus infection suppressed osteoblast markers only in male mice. Consistent with effects on bone health, male mice with H. hepaticus infection had more severe colitis as determined by histology and elevated levels of inflammatory cytokines in the colon. Although H. hepaticus levels in the stool appeared similar in male and female mice 1 week after infection, by 6 weeks, H. hepaticus levels were greater in male mice, indicating that H. hepaticus survival and virulence within the gastrointestinal tract could be gender dependent.
CONCLUSION: In summary, H. hepaticus-induced colitis severity and associated bone loss is gender regulated, possibly as a result of gender-specific effects on H. hepaticus colonization in the mouse gastrointestinal tract and the consequent immunopathological responses.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23702805      PMCID: PMC4127911          DOI: 10.1097/MIB.0b013e318289e17b

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  62 in total

1.  Natural history of bone metabolism and bone mineral density in children with inflammatory bowel disease.

Authors:  Francisco A Sylvester; Nancy Wyzga; Jeffrey S Hyams; Patricia M Davis; Trudy Lerer; Katherine Vance; Gillian Hawker; Anne M Griffiths
Journal:  Inflamm Bowel Dis       Date:  2007-01       Impact factor: 5.325

Review 2.  Management of glucocorticoid-induced osteoporosis.

Authors:  Juliet Compston
Journal:  Nat Rev Rheumatol       Date:  2010-02       Impact factor: 20.543

3.  Fracture risk is increased in Crohn's disease, but not in ulcerative colitis.

Authors:  P Vestergaard; K Krogh; L Rejnmark; S Laurberg; L Mosekilde
Journal:  Gut       Date:  2000-02       Impact factor: 23.059

4.  Colonization of the cecal mucosa by Helicobacter hepaticus impacts the diversity of the indigenous microbiota.

Authors:  Carole J Kuehl; Heather D Wood; Terence L Marsh; Thomas M Schmidt; Vincent B Young
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

Review 5.  Emergence of diverse Helicobacter species in the pathogenesis of gastric and enterohepatic diseases.

Authors:  J V Solnick; D B Schauer
Journal:  Clin Microbiol Rev       Date:  2001-01       Impact factor: 26.132

6.  Altered bone metabolism in inflammatory bowel disease: there is a difference between Crohn's disease and ulcerative colitis.

Authors:  S Ardizzone; S Bollani; P Bettica; M Bevilacqua; P Molteni; G Bianchi Porro
Journal:  J Intern Med       Date:  2000-01       Impact factor: 8.989

Review 7.  Proinflammatory cytokines in the pathogenesis of inflammatory bowel diseases.

Authors:  Warren Strober; Ivan J Fuss
Journal:  Gastroenterology       Date:  2011-05       Impact factor: 22.682

8.  Interleukin-10-deficient mice develop chronic enterocolitis.

Authors:  R Kühn; J Löhler; D Rennick; K Rajewsky; W Müller
Journal:  Cell       Date:  1993-10-22       Impact factor: 41.582

9.  In vitro and in vivo characterization of Helicobacter hepaticus cytolethal distending toxin mutants.

Authors:  Vincent B Young; Kimberly A Knox; Jason S Pratt; Jennifer S Cortez; Linda S Mansfield; Arlin B Rogers; James G Fox; David B Schauer
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

10.  Interleukin 10-deficient mice develop osteopenia, decreased bone formation, and mechanical fragility of long bones.

Authors:  Rivka Dresner-Pollak; Nir Gelb; Daniel Rachmilewitz; Fanny Karmeli; Miron Weinreb
Journal:  Gastroenterology       Date:  2004-09       Impact factor: 22.682

View more
  31 in total

1.  Alterations to the Gut Microbiome Impair Bone Strength and Tissue Material Properties.

Authors:  Jason D Guss; Michael W Horsfield; Fernanda F Fontenele; Taylor N Sandoval; Marysol Luna; Fnu Apoorva; Svetlana F Lima; Rodrigo C Bicalho; Ankur Singh; Ruth E Ley; Marjolein Ch van der Meulen; Steven R Goldring; Christopher J Hernandez
Journal:  J Bone Miner Res       Date:  2017-03-27       Impact factor: 6.741

2.  Loss of interleukin-10 exacerbates early Type-1 diabetes-induced bone loss.

Authors:  Naiomy D Rios-Arce; Andrew Dagenais; Derrick Feenstra; Brandon Coughlin; Ho Jun Kang; Susanne Mohr; Laura R McCabe; Narayanan Parameswaran
Journal:  J Cell Physiol       Date:  2019-09-19       Impact factor: 6.384

3.  Probiotic Lactobacillus reuteri Prevents Postantibiotic Bone Loss by Reducing Intestinal Dysbiosis and Preventing Barrier Disruption.

Authors:  Jonathan D Schepper; Fraser L Collins; Naiomy Deliz Rios-Arce; Sandi Raehtz; Laura Schaefer; Joseph D Gardinier; Robert A Britton; Narayanan Parameswaran; Laura R McCabe
Journal:  J Bone Miner Res       Date:  2019-01-28       Impact factor: 6.741

Review 4.  Human Relevance of Preclinical Studies on the Skeletal Impact of Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.

Authors:  Swati Rajput; Poonam Mehta; Monika Mittal; Singh Rajender; Naibedya Chattopadhyay
Journal:  Calcif Tissue Int       Date:  2021-02-09       Impact factor: 4.333

5.  Gut-derived serotonin contributes to bone deficits in colitis.

Authors:  B Lavoie; J A Roberts; M M Haag; S N Spohn; K G Margolis; K A Sharkey; J B Lian; G M Mawe
Journal:  Pharmacol Res       Date:  2018-07-17       Impact factor: 7.658

6.  Probiotic use decreases intestinal inflammation and increases bone density in healthy male but not female mice.

Authors:  Laura R McCabe; Regina Irwin; Laura Schaefer; Robert A Britton
Journal:  J Cell Physiol       Date:  2013-08       Impact factor: 6.384

7.  Post-antibiotic gut dysbiosis-induced trabecular bone loss is dependent on lymphocytes.

Authors:  Naiomy Deliz Rios-Arce; Jonathan D Schepper; Andrew Dagenais; Laura Schaefer; Connor S Daly-Seiler; Joseph D Gardinier; Robert A Britton; Laura R McCabe; Narayanan Parameswaran
Journal:  Bone       Date:  2020-02-21       Impact factor: 4.398

8.  Novel Helicobacter species H.japonicum isolated from laboratory mice from Japan induces typhlocolitis and lower bowel carcinoma in C57BL/129 IL10-/- mice.

Authors:  Zeli Shen; Yan Feng; Sureshkumar Muthupalani; Alexander Sheh; Lenzie E Cheaney; Christian A Kaufman; Guanyu Gong; Bruce J Paster; James G Fox
Journal:  Carcinogenesis       Date:  2016-09-21       Impact factor: 4.944

Review 9.  Prebiotic and Probiotic Regulation of Bone Health: Role of the Intestine and its Microbiome.

Authors:  Laura McCabe; Robert A Britton; Narayanan Parameswaran
Journal:  Curr Osteoporos Rep       Date:  2015-12       Impact factor: 5.096

Review 10.  Advances in Probiotic Regulation of Bone and Mineral Metabolism.

Authors:  Laura R McCabe; Narayanan Parameswaran
Journal:  Calcif Tissue Int       Date:  2018-02-16       Impact factor: 4.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.